My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
Welcome

Analysts’ Top Healthcare Picks: Pfizer (PFE)

Analysts fell to the sidelines weighing in on and Pfizer (PFEResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Pfizer (PFE)

In a report issued on August 2, Lorenzo Biasio from Credit Suisse maintained a Hold rating on Pfizer, with a price target of $40.50. The company’s shares closed last Tuesday at $41.85.

According to TipRanks.com, Biasio is a 4-star analyst with an average return of 8.4% and a 61.9% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Coherus Biosciences, Intuitive Surgical, and Merck & Company.

The word on The Street in general, suggests a Hold analyst consensus rating for Pfizer with a $45.38 average price target, which is a 7.6% upside from current levels. In a report issued on July 29, Mizuho Securities also maintained a Hold rating on the stock with a $43.00 price target.

See the top stocks recommended by analysts >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PFE: